drugset / Trial / NCT00079300

Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer

NCT00079300

Phase 1 Completed National Naval Medical Center
RandomizedDouble-blindTreatment

Summary

RATIONALE: Biological therapies, such as imiquimod cream, work in different ways to stimulate the immune system and stop tumor cells from growing. PURPOSE: This randomized phase I trial is studying how well imiquimod cream works in treating patients with basal cell skin cancer.

Timeline

Start
2004-01
Primary completion
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Imiquimod Other / unclassified 5 % Topical

Indications